| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/27/2008 | CN101130536A Flavanone compound and uses thereof |
| 02/27/2008 | CN101130491A Oligomer having fatty acid synthase restraining activity and uses thereof |
| 02/27/2008 | CN101130092A Application of recombinant adenovirus in producing antineoplastic medicine |
| 02/27/2008 | CN101130089A Nucleoside phosphorus acylated coupling chitosan derivant and method of producing the same and application of the same |
| 02/27/2008 | CN101130087A Medicament carrier solution for abdominal cavity chemotherapy and pharmaceutical composition thereof |
| 02/27/2008 | CN101130082A Novel photosensitive agent with function of carrying oxygen |
| 02/27/2008 | CN101130081A Use of PNAS-4 gene in preparing antineoplastic and antineoplastic auxiliary medicament |
| 02/27/2008 | CN101130078A Intrathecal administration of rituximab for treatment of central nervous system lymphomas |
| 02/27/2008 | CN101130051A Traditional Chinese medicine for treating stomach cancer |
| 02/27/2008 | CN101130002A Traditional Chinese medicine for treating lesion before stomach cancer |
| 02/27/2008 | CN101129976A Orally taken traditional Chinese medicine composition for treating mammary cancer |
| 02/27/2008 | CN101129970A Traditional Chinese medicine for treating metaphase and advanced liver cancer |
| 02/27/2008 | CN101129968A Traditional Chinese medicine for treating metaphase and advanced cancer of the esophagus |
| 02/27/2008 | CN101129945A Traditional Chinese medicine for treating diffuse liver cancer |
| 02/27/2008 | CN101129917A Method of preparing medicine soup for treating cancer of the lungs |
| 02/27/2008 | CN101129896A Chinese medicinal herb agentia for treating tumour disease |
| 02/27/2008 | CN101129873A Orally taken traditional Chinese medicine prescription for treating cancer of the lungs |
| 02/27/2008 | CN101129804A Traditional Chinese medicine for treating primary liver cancer |
| 02/27/2008 | CN101129803A Traditional Chinese medicine for treating stomach cancer stomachache |
| 02/27/2008 | CN101129802A Traditional Chinese medicine for treating liver cancer pain |
| 02/27/2008 | CN101129748A Proprietary Chinese medicine for treating cancer of the lungs and method of preparing the same |
| 02/27/2008 | CN101129682A Traditional Chinese medicine for treating late ascites of liver cancer |
| 02/27/2008 | CN101129669A Traditional Chinese medicine for treating late stomach cancer |
| 02/27/2008 | CN101129655A Orally taken traditional Chinese medicine prescription for treating nasopharyngeal carcinoma |
| 02/27/2008 | CN101129607A Traditional Chinese medicine oral liquid for treating damnification of immunity function after chemotherapy of cancer of the esophagus patient |
| 02/27/2008 | CN101129521A Effective component of hedyotis diffusa and method of preparing the same and application |
| 02/27/2008 | CN101129493A Antineoplastic anti-AIDS pharmaceutical composition and method of preparing the same |
| 02/27/2008 | CN101129436A Dandelion medicinal granules and method of producing the same |
| 02/27/2008 | CN101129433A Method for extracting active component of edible burdock |
| 02/27/2008 | CN101129419A Emulsified pharmaceutical composition containing oleum fructus bruceae and processes for producing same |
| 02/27/2008 | CN101129375A Vinorelbine solid lipid nano granule, freeze drying formulated product and method of preparing the same |
| 02/27/2008 | CN101129374A Vinflunine pharmaceutical composition and method of producing the same and application of the same |
| 02/27/2008 | CN101129353A Use of 7-hydroxyl-3-[(4-hydroxyl)-3-(3-methyl- butyl-2- alkenyl) phenyl]-4H-1-benzopyran-4-ket |
| 02/27/2008 | CN101129349A Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 02/27/2008 | CN101129348A Use of dipropylacetic acid or its salt in treating tumour |
| 02/27/2008 | CN101129338A Minuteness anti-cancer medicine paclitaxel of novel technique supercritical fluid |
| 02/27/2008 | CN101129337A Method of producing water-solubility hypocrellin titanium dioxide nano granule |
| 02/27/2008 | CN101129335A Use of nano structured lipid carrier drug feeding system |
| 02/27/2008 | CN101129331A Method of preparing transparent water dispersion type lycopene concentrated liquor |
| 02/27/2008 | CN101129151A Multifunctional healthy tea |
| 02/27/2008 | CN100371450C Fatty acid extract of Antrodiacamphorata mycelium and its uses |
| 02/27/2008 | CN100371444C VEGF expression-inhibiting siRNA and application thereof |
| 02/27/2008 | CN100371442C Ligand/receptor specificity exchangers that redirect antibodies to receptors on pathogen |
| 02/27/2008 | CN100371350C Microbe composite polysaccharide for suppressing cancer cell and its preparation method |
| 02/27/2008 | CN100371347C Active material of polypeptide proteins in bloody clam, preparation method and usage |
| 02/27/2008 | CN100371344C Cerbera manghas heteroside derivative, its preparing method and use |
| 02/27/2008 | CN100371325C Indenoindole ketone kind compound, its preparation method and use |
| 02/27/2008 | CN100371324C Dialkyl and diaryl tetrasubstituted heterocyclic compounds, preparing process and use thereof |
| 02/27/2008 | CN100371323C Cyanopyrrolidine derivatives |
| 02/27/2008 | CN100371021C Anti-lymphadenoma gene family specificity nucleic acid vaccine combination |
| 02/27/2008 | CN100370993C Medicinal composition with heat-clearing, fire-draining and detoxification function |
| 02/27/2008 | CN100370989C Use of 5-HT5-ligands in treatment of neurodegenerative and neuropsychiatric disturbances |
| 02/27/2008 | CN100370987C Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 02/27/2008 | CN100370981C Application of Maoeryisu for pharmacy |
| 02/27/2008 | CN100370980C C-2' methylated derivatives of paclitaxel for use as antitumour agents |
| 02/27/2008 | CN100370976C Medicine containing shikonin compound as active component |
| 02/27/2008 | CN100370974C Bufonin preparation for cancer treating |
| 02/27/2008 | CN100370968C Quercetin long-acting liposome powder for injection and its preparing method |
| 02/27/2008 | CA2660758A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
| 02/26/2008 | US7335774 Quinolinone derivatives |
| 02/26/2008 | US7335773 induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; exhibit antiviral and antitumor properties |
| 02/26/2008 | US7335770 Triazine compounds and their analogs, compositions, and methods |
| 02/26/2008 | US7335765 Nucleoside and oligonucleotide analogues |
| 02/26/2008 | US7335756 Isolated nucleic acid comprising polynucleotide of given sequence; diagnostic kits; use in treatment of cancer |
| 02/26/2008 | US7335723 Melanin-concentrating hormone antagonists |
| 02/26/2008 | US7335691 Esterified rosins (via polyalcohols) dissolved in solvent of C2-C4 alcohols with C5-C7 hydrocarbons |
| 02/26/2008 | US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide |
| 02/26/2008 | US7335681 Inhibit glucosyl ceramide (GlcCer) formation by inhibiting the enzyme GlcCer synthase; Gaucher's disease, Tay Sachs disease, Fabry's disease. Sandhoff disease or GM1 gangliosidosis |
| 02/26/2008 | US7335679 Wortmannin analogs and methods of using same |
| 02/26/2008 | US7335677 Inhibitors of dipeptidyl peptidase IV |
| 02/26/2008 | US7335674 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 02/26/2008 | US7335662 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 4-(4-pyrimid-2-ylaminosulfonyl-1,4-phenylene-aminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole |
| 02/26/2008 | US7335659 Substituted 10-aryl-11H-benzo[b]fluorenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 02/26/2008 | US7335656 Medical devices employing triazine compounds and compositions thereof |
| 02/26/2008 | US7335655 Treating asthma with e.g. 2-(3-methoxyphenyl)-N-[5-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yl]acetamide; potent, yet selective modulators of adenosine receptors |
| 02/26/2008 | US7335654 Phosphodiesterase 4 inhibitors |
| 02/26/2008 | US7335645 For prophylaxis or treatment of skin or mucosa, autoimmune diseases and inflammation |
| 02/26/2008 | US7335635 14-3-3 binding molecules as sensitizers for anticancer therapies |
| 02/26/2008 | US7335482 Method using neutral amino acid transporter expressing cell |
| 02/26/2008 | US7335376 Method for photodynamic therapy and applicator for carrying out said therapy |
| 02/26/2008 | US7335154 Radiotherapy |
| 02/26/2008 | CA2353788C Human cervical cancer 1 protooncogene and protein encoded therein |
| 02/26/2008 | CA2230159C Use of aminoadamantane compounds as immunoregulators |
| 02/26/2008 | CA2078544C Method and compositions for treating injury |
| 02/21/2008 | WO2008022263A2 Methods for lymph system imaging |
| 02/21/2008 | WO2008022013A1 Kinase inhibitors |
| 02/21/2008 | WO2008022002A2 2-amido-4-isoxazolyl thiazole compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 02/21/2008 | WO2008021924A1 Pyrrolotriazine kinase inhibitors |
| 02/21/2008 | WO2008021891A2 Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects |
| 02/21/2008 | WO2008021859A1 Pyrrolotriazine kinase inhibitors |
| 02/21/2008 | WO2008021781A1 Triazolotriazines as kinase inhibitors |
| 02/21/2008 | WO2008021389A2 Using pi3k and mek modulators in treatments of cancer |
| 02/21/2008 | WO2008021364A2 Triazole compounds that modulate hsp90 activity |
| 02/21/2008 | WO2008021338A2 Tricyclic oxazolidone derivatives useful as pr modulators |
| 02/21/2008 | WO2008020625A1 Dibenzoylmethane compound and pharmaceutical composition comprising the compound as active ingredient |
| 02/21/2008 | WO2008020622A1 NOVEL THIENO[2,3-d]PYRIMIDINE COMPOUND |
| 02/21/2008 | WO2008020606A1 Antiangiogenic agent |
| 02/21/2008 | WO2008020596A2 Treating or preventing cancers over-expressing reg4 or kiaa0101 |
| 02/21/2008 | WO2008020586A1 Diagnosis and treatment of cancer using anti-desmoglein-3 antibody |
| 02/21/2008 | WO2008020584A1 Stable lyophilized preparation |